POS1201 CHI3L1 AND CHI3L2 REPRESENT TWO HIGHLY SPECIFIC SYNOVIAL FIBROBLAST-RELATED BIOMARKERS IN SEROPOSITIVE AND –NEGATIVE RHEUMATOID ARTHRITIS
Alexandra Khmelevskaya(University of Zurich), Raphael Micheroli(University of Zurich), Douglas J. Veale(St. Vincent's University Hospital), Chantal Pauli(University of Zurich), M. Houtman(University of Zurich), Oliver Distler(University Hospital of Zurich), A. Ramming(Universitätsklinikum Erlangen), Caroline Ospelt(University of Zurich), Mattia Angeli(Universitätsklinikum Erlangen), U. Fearon(Trinity College Dublin), H. Mohammadian(Universitätsklinikum Erlangen), Kristina Bürki(University of Zurich), Adrian Ciurea(University of Zurich)
Cited by 1
Related Papers
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432